Divesiran

DB18646InvestigationalGene Therapies

Divesiran is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.

Mechanism
Curator reviewed
Code names
SLN-124

Resolves to

What you can answer from here — as of October 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Divesiran, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account